Island Pharmaceuticals Ltd
ILA.AX
$0.11
Closing
0.00
1D
▲101.31%
YTD
ILA
BBG00ZK1B0V0
Check if the stock is halal
Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.
We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.
Get started from just $6.99/month
Market cap
$19.75M
Analysts' Rating
-
Price Target (Mean)
0.00
Total Analysts
0
P/E
Operating Margin
-177929.47%
Beta
0.80
Revenue Growth
-85.47%
52 week high
$0.18
52 week low
$0.03
Div. Yield
%
EPS Growth
0.00
Company Profile
Island Pharmaceuticals Limited is an Australia-based drug repurposing company, focused on areas of need for antiviral therapeutics to address infectious diseases. The Company’s lead asset is ISLA-101, a drug, being repurposed for the prevention and treatment of dengue fever and other mosquito (or vector) borne diseases. ISLA-101 has been shown to have activity against all four strains of dengue virus as well as other flaviviruses such as Zika virus, West Nile virus, and Yellow Fever virus, as well as Chikungunya virus. The Company operates a single segment, being research and development activities principally in the geographic regions of Australia and the United States. Its subsidiary is Isla Pharmaceuticals Inc.
